Pharma Stocks
-
Jasper Therapeutics to Acquire Kira Pharmaceuticals in $132 Million Merger Agreement
Jasper Therapeutics completed its acquisition of Kira Pharmaceuticals in an all-stock transaction. Concurrent with the closing, Jasper raised approximately $132…
Read More » -
Does Zasocitinib’s Phase 3 Success in Hard-to-Treat Psoriasis Areas Change The Bull Case For Takeda Pharmaceutical (TSE:4502)?
In July 2026, Takeda reported positive Phase 3 results for its oral TYK2 inhibitor zasocitinib in adults with moderate-to-severe plaque…
Read More » -
Is Amneal Pharmaceuticals (AMRX) Fairly Valued After Its Sharp Rerating?
Amneal Pharmaceuticals (AMRX) is back in focus after a recent review highlighted strong long term shareholder returns, alongside slower projected…
Read More » -
Ligand Pharmaceuticals (LGND) Closes XOMA Deal, Is The Stock Still Below Fair Value?
Ligand Pharmaceuticals (LGND) has completed its approximately US$739 million cash acquisition of XOMA Royalty Corporation, adding seven commercial products and…
Read More » -
Johnson & Johnson vs. Eli Lilly and: Which Pharma Giant Stock Is a Better Buy in 2026?
Determining where to allocate capital in the healthcare sector often involves choosing between established stability and aggressive growth. Both Johnson…
Read More » -
Retail Bets On Big Pharma Buyouts As J&J Chases No. 1 Oncology Spot
J&J’s fast-growing Inlexzo bladder-cancer franchise could make IBRX either strategically attractive or a direct rival. J&J said it aims to…
Read More » -
Tarsus Pharmaceuticals (TARS) Replaces Its Commercial Chief While iRenix Talks Continue
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St.…
Read More » -
Agios Pharmaceuticals (AGIO) Wins Priority Review, Is The Stock Now Fully Valued?
Agios Pharmaceuticals (AGIO) is back in focus after the U.S. Food and Drug Administration accepted its supplemental New Drug Application…
Read More » -
ELTP vs. CPIX: Which Pharma Stock Is the Better Buy Right Now? – July 15, 2026
Specialty pharmaceutical companies continue to operate in a competitive healthcare environment influenced by evolving regulatory standards, product innovation and demand…
Read More » -
Is Silo Pharma, Inc. (SILO) Stock an AI Opportunity After NVIDIA Partnership Boosts QwikAgents Platform?
We recently compiled a list of the 7 Best Psychedelic Stocks to Buy According to Analysts. Silo Pharma, Inc. (NASDAQ:SILO)…
Read More »